naringenin has been researched along with Blood Poisoning in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cui, W; Hu, G; Liu, J; Mu, L; Qiao, L | 1 |
| Cheng, L; Liu, D; Liu, W; Wang, M; Ye, G; Yin, X; Zhang, Q | 1 |
2 other study(ies) available for naringenin and Blood Poisoning
| Article | Year |
|---|---|
Protective Effects of Naringenin in a Rat Model of Sepsis-Triggered Acute Kidney Injury via Activation of Antioxidant Enzymes and Reduction in Urinary Angiotensinogen.
Topics: Acute Kidney Injury; Angiotensinogen; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cecum; Disease Models, Animal; Flavanones; Kidney; Kidney Glomerulus; Rats; Rats, Wistar; Reactive Oxygen Species; Sepsis; Urinary Tract | 2019 |
Mechanism of Naringenin Blocking the Protection of LTB4/BLT1 Receptor Against Septic Cardiac Dysfunction.
Topics: Adenylate Kinase; Animals; Apoptosis; Disease Models, Animal; Flavanones; Heart Diseases; Inflammation; Interleukin-6; Leukotriene B4; Lipopolysaccharides; Male; Mice; Myocardium; Myocytes, Cardiac; NF-kappa B; NF-KappaB Inhibitor alpha; Receptors, Leukotriene B4; Sepsis; Signal Transduction; Tumor Necrosis Factor-alpha | 2020 |